The TET1 enzyme steers us through fetal development and fights cancer

Control of our genes
The complete human genetic code was mapped in 2000. However, it has become clear that the genetic code itself only in part can answer how an individual develops and is protected against disease. What is detrimental is also how our genes are controlled – what genes are on or off at certain times. This is in part regulated by specific cellular enzymes that can attach small chemical groups, methyl groups, to our DNA:

“The methyl groups can turn off the gene that lies in a stretch of DNA where it is added. TET1 is another type of enzyme that can fine tune the signals that control gene activity by changing the methyl groups which thereafter are removed,” says Kristian Helin.

TET1 controls fetal development
Kristine Williams, Jesper Christensen and Marianne Terndrup Pedersen are the three key persons in the Helin laboratory at BRIC contributing with the new results:

“Our most important finding is that TET1 acts like a safe guard and prevents that methyl groups are attached to genes that needs to be active for normal growth and development of our cells. That is crucial for normal fetal development,” says PhD student Kristine Williams.

Selected genes needs to be active in the stem cells of our body, before the cells are specialised to one of the more than 200 specialised cell types that exist in our body. Other genes need only to be active in specialised cell types as for example liver cells, muscle cells or nerve cells.

When cancer cells develop
The results also contribute to the understanding of what goes wrong when some cells accidently develop into cancer cells. The functions of our body are dependent on constant cellular renewal through division of the cells. A large cellular machinery ensures that our DNA is intact and copied correctly when our cells divide. This is crucial for normal development and function of the cells. In a worst case scenario, changes in the DNA, so called mutations, can result in development of cancer. Specialised genes called tumor suppressor genes are especially important for fighting cancer:

“If methyl groups are deployed to genes that are usually active in normal cells, the genes are turned off and this can be detrimental. If it happens to tumor suppressor genes, it can be a step towards cancer development as the genes no longer can protect against unintended cell growth,” says Kristian Helin.

TET enzymes and blood cancers
So TET1 can fight cancers by controlling the activity and protective function of tumor suppressor genes. Our cells also contain a close relative to TET1, the TET2 enzyme, which is the most frequently mutated gene in blood cancers. The researches at BRIC has discovered that TET2 also controls gene activity by facilitating removal of methyl groups from the DNA and they are currently extending these studies to cellular models for cancer development. Results from these studies will supply insight into the mechanisms leading to blood cancers and can potentially lead to development of new therapeutics.

Original paper: “TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity”, Williams et al., Nature April 13, 2011